New insights into systemic amyloidosis: The importance of diagnosis of specific type

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 3, 2007, Pages 196-203

  Picken, Maria M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amyloid; Diagnosis; Hereditary amyloidosis; Periodic fevers; Systemic amyloidosis

Indexed keywords

AMYLOID PROTEIN; APOLIPOPROTEIN A1; CONGO RED; FIBRINOGEN; IMMUNOGLOBULIN LIGHT CHAIN; PERMANGANATE POTASSIUM; THYROID HORMONE;

AMINO ACID SUBSTITUTION; AMYLOIDOSIS; ANTIGEN ANTIBODY REACTION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FAMILIAL AMYLOIDOSIS; GENE MUTATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY BIOPSY; MONOCLONAL IMMUNOGLOBULINEMIA; MORBIDITY; MORTALITY; NERVE BIOPSY; PATHOLOGY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

AMYLOID; AMYLOIDOSIS; AMYLOIDOSIS, FAMILIAL; COLORING AGENTS; CONGO RED; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; SERUM AMYLOID A PROTEIN; STAINING AND LABELING;

EID: 34247257162     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3280bdc0db     Document Type: Review

References (30)

1. Westermark P, Benson MD, Buxbaum JN, et al. Nomenclature Committee of the International Society of Amyloidosis. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2005; 12:1-4.
2. Herrera GA, Picken MM. Renal Diseases associated with plasma cell dyscrasias, amyloidoses, Waldenstrom macroglobulinemia and cryoglobulinemic nephropathies. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's Pathology of the Kidney, 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. pp. 853-910. This is an updated overview of amyloidoses and comprehensive review of renal pathology associated with plasma cell dyscrasia and amyloidoses in general.
3. Obici L, Perfetti V, Palladini G, et al. Clinical aspects of systemic amyloidosis. Bioch Biophys Acta 2005; 1253:11-22.
4. Lachmann HJ, Hawkins PN. Systemic amyloidosis. Curr Opinion Pharmacol 2006; 6:1-7. This is a recent overview of systemic amyloidoses emphasizing new therapeutic strategies.
5. Comenzo R. Amyloidosis. Curr Treat Options Oncol 2006; 7:225-236. This provides an update on systemic amyloidoses with emphasis on the clinical picture and treatments.
6. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006; 17:3458-3471. This recent review focuses on renal amyloidoses.
7. Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR. Amyloidosis: diagnosis and management. Clin Lymphoma Myeloma 2005; 6:208-219.
8. Sanchorawala V, Blanchard E, Seldin DC, et al. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol 2006; 81:692-695. The authors report the largest series and longest follow-up of high-dose chemotherapy and autologous stem cell rescue in AL amyloidosis.
9. Picken MM. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis. Contrib Nephrol 2007; 153:135-155. This is a comprehensive updated review of pathology and differential diagnosis of amyloidoses with emphasis on renal amyloidoses. Current diagnostic standards are reviewed, including interpretation of Congo red stain and alternative methods as well as proposed recommendations for amyloid typing.
10. Gono T, Yazaki M, Fushimi T, et al. AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment. Am J Kid Dis 2006; 47:908-914.
11. Nasr SH, Colvin R, Markowitz GS. IgG1 lambda light and heavy chain renal amyloidosis. Kidney Int 2006; 70:7.
12. Komatsuda A, Maki N, Wakui H, et al. Development of systemic lambda-light chain amyloidosis in a patient with gamma-heavy chain deposition disease during long-term follow-up. Nephrol Dial Transplant 2005; 20:434-437.
13. Gertz MA, Merlini G, Treon SP. Amyloidosis and Waldenstrom's macroglobulinemia. Hematology Am Soc Hematol Educ Program 2004; 257-282.
14. Paccalin M, Hachulla E, Cazalet C, et al. Localized amyloidosis: a survey of 35 French cases. Amyloid 2005; 12:239-245.
15. Biewend M, Menke DM, Calamia KT. The spectrum of localized amyloidosis: a case series of 20 patients and review of the literature. Amyloid 2006;13:135-142.
16. Rocken C, Shakespeare A. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 2002;440:111-122.
17. Lachmann HJ, Goodman HJB, Gallimore J, et al. Characteristics and clinical outcome of 340 patients with systemic AA amyloidosis. In: Grateau G, Kyle RA, Skinner M, editors. Amyloid and amyloidosis. Boca Raton, FL: CRC Press; 2005. pp. 173-175.
18. Connolly JO, Gillmore JD, Lachmann HJ, et al. Renal amyloidosis in intravenous drug users. QJM 2006; 99:737-742.
19. Atta MG, Choi MJ, Longenecker JC, et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am J Med 2005; 118:1288.
20. Saito A, Gejyo F. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients. Ther Apher Dial 2006; 10:316-320.
21. Dember LM, Jaber BL. Dialysis-related amyloidosis: late finding or hidden epidemic? Semin Dial 2006; 19:105-109.
22. Connors LH, Prokayeva T, Akar H, et al. Familial amyloidosis: recent novel and rare mutations in a clinical population. In: Grateau G, Kyle RA, Skinner M, editors. Amyloid and Amyloidosis. Boca Raton, FL: CRC Press; 2005. pp. 360-362.
23. Hawkins PN. Hereditary systemic amyloidoses with renal involvement. J Nephrol 2003; 16:443-448.
24. Lachmann HJ, Booth DR, Booth SE, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002; 346:1786-1791.
25. Kang HG, Bybee A, Ha IS, et al. Hereditary amyloidosis in early childhood associated with a novel insertion-deletion (indel) in the fibrinogen A alpha chain gene. Kidney Int 2005; 68:1994-1998.
26. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005; 62:1057-1062.
27. Lobato L, Beirao I, Silva M, et al. End-stage disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid 2004; 11:27-37.
28. Haagsma EB, Hawkins PN, Benson MD, et al. Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish families. Amyloid 2004; 11:44-49.
29. Westermark P, Bergstrom J, Solomon A, et al. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003; 1:48-54.
30. Picken MM, Leya F, Picken RN. Wild type transthyretin-derived senile systemic amyloidosis with limited proteolytic digestion of the monomer: clinico-pathologic studies with DNA and amyloid protein characterization. In: Grateau G, Kyle RA, Skinner M, editors. Amyloid and amyloidosis. Boca Raton, FL: CRC Press; 2005. pp. 466-467.